Janux Therapeutics (JANX) Return on Sales Growth (1y) (2022 - 2026)
Janux Therapeutics (JANX) Return on Sales Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,011.97 Bn | 67,011.68 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.88 Bn | 467.08 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 122.20 Bn | 114.96 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.17 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.85 Bn | 50.67 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 0.00 |
| 10 | Janux Therapeutics | 993.25 Mn | 993.25 Mn | - | 73.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.00 |
| Dec 31, 2025 | 42.00 |
| Sep 30, 2025 | 765.00 |
| Jun 30, 2025 | -1,445.00 |
| Mar 31, 2025 | 128.00 |
| Dec 31, 2024 | -82.00 |
| Sep 30, 2024 | -767.00 |
| Jun 30, 2024 | 18.00 |
| Mar 31, 2024 | -188.00 |
| Dec 31, 2023 | 1.00 |
| Sep 30, 2023 | 19.00 |
| Jun 30, 2023 | -28.00 |
| Mar 31, 2023 | 4.00 |
| Dec 31, 2022 | 3.00 |
| Sep 30, 2022 | 42.00 |
| Jun 30, 2022 | -10.00 |
| Mar 31, 2022 | -24.00 |